Cargando…

Does the road to primary prevention of inflammatory bowel disease start from childhood?

Detalles Bibliográficos
Autores principales:	Kedia, Saurabh, Ahuja, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218530/ https://www.ncbi.nlm.nih.gov/pubmed/35774343 http://dx.doi.org/10.1002/jgh3.12782

Ejemplares similares

Management of inflammatory bowel disease in older persons: evolving paradigms
por: Kedia, Saurabh, et al.
Publicado: (2018)

Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
por: Kedia, Saurabh, et al.
Publicado: (2021)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

Personalized medicine to implementation science: Thiopurines set for the leap
por: Sharma, Vishal, et al.
Publicado: (2022)

Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
por: Markandey, Manasvini, et al.
Publicado: (2021)

Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India
por: Harsh, Parnita, et al.
Publicado: (2017)

Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
por: Vuyyuru, Sudheer K, et al.
Publicado: (2022)

Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India
por: Tomar, Sanjeevani K, et al.
Publicado: (2017)

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
por: Singh, Arshdeep, et al.
Publicado: (2023)

High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
por: Kante, Bhaskar, et al.
Publicado: (2023)

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
por: Agarwal, Ashish, et al.
Publicado: (2018)

Human gut microbiome: A primer for the clinician
por: Kedia, Saurabh, et al.
Publicado: (2023)

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease
por: Tomar, Sanjeevani K, et al.
Publicado: (2019)

Pivot to Asia: inflammatory bowel disease burden
por: Singh, Prashant, et al.
Publicado: (2017)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Predictive factors for malignancy in undiagnosed isolated small bowel strictures
por: Sonika, Ujjwal, et al.
Publicado: (2017)

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
por: Kante, Bhaskar, et al.
Publicado: (2022)

Are we nearly there yet? Starts and stops on the road to use of polygenic scores
por: Moorthie, Sowmiya, et al.
Publicado: (2023)

Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease
por: Gupta, Arti, et al.
Publicado: (2022)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022)

Noncommunicable chronic disease prevention should start from childhood
por: Yan, Yinkun, et al.
Publicado: (2021)

Can Statin Prevent the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Disease?
por: Jang, Hyun Joo
Publicado: (2019)

Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn’s disease and intestinal tuberculosis
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2021)

Childhood leukaemia and nuclear installations: the long and winding road
por: Wakeford, R
Publicado: (2014)

Does Radiation Exposure from Abdominal Computed Tomography Increase Cancer Risk in Patients with Inflammatory Bowel Disease and Behçet Disease?
por: Lim, Yun Jeong
Publicado: (2014)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
por: Kim, Kwang Woo, et al.
Publicado: (2023)

Protocols for the obvious: Where does it start, and stop?
por: Girbes, Armand R. J., et al.
Publicado: (2017)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
por: Park, Yong Eun
Publicado: (2022)

Biomarkers in Inflammatory Childhood Diseases
por: de Jager, Wilco, et al.
Publicado: (2013)

Preventing Road Deaths—Time for Data
Publicado: (2010)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_00kva8a1hn0fhvgdrliop8rejn